Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-046083

Chief Operating Officer sold 3,125 shares at an average $37.17 ($116,155)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2021-07-07 Sale −871 $39.42 $34,335 57,233 D: show line 1 in the form
ADAMS R MARK Chief Operating Officer 2021-07-08 Sale −2,254 $36.30 $81,820 54,979 D: show line 2 in the form
Open-market sales · 3,125 sh · avg $37.17 · $116,155
Loading xslF345X03/doc4.xml…